Inferring relevant control mechanisms for interleukin-12 signaling in nave CD4 T cells

Immunology and Cell Biology

Volumn 89, Issue 1, 2011, Pages 100-110

  Finley, Stacey D ^a   Gupta, Deepti ^a   Cheng, Ning ^b   Klinke, David J ^b,c  

^a Northwestern University   (United States)

^b West Virginia University   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Bayesian inference; CD4 + T cells; interleukin 12; ordinary differential equations; signal transduction

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; JANUS KINASE; STAT4 PROTEIN;

ANIMAL CELL; ARTICLE; BAYESIAN LEARNING; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSDUCER;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CRICETINAE; FEMALE; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MODELS, IMMUNOLOGICAL; RECEPTORS, INTERLEUKIN-12; SIGNAL TRANSDUCTION; SPLEEN; STAT4 TRANSCRIPTION FACTOR;

EID: 78651071868     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.69     Document Type: Article

References (58)

1. Janeway C. Immunobiology 5: The Immune System in Health and Disease, 5th edn. Garland Publishing: New York, 2001.
2. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions in helper T cells. Adv Immunol 1989; 46: 111-147.
3. + T cells. Annu Rev Immunol 1994; 12: 635-673.
4. Bi Y, Liu G, Yang R. Th17 cell induction and immune regulatory effects. J Cell Physiol 2007; 211: 273-278.
5. Rosenberg SA. A new era of cancer immunotherapy: converting theory to performance. CA: Cancer J Clin 1999; 49: 70-73.
6. Martin R, Sturzebecher C-S, McFarland HF. Immunotherapy of multiple sclerosis: Where are we? Where should we go? Nat Immunol 2001; 2: 785-788.
7. Lam WK, Watkins DN. Lung cancer: future directions. Respirology 2007; 12: 471-477.
8. + T cells through IL12 produced listeria-induced macrophages. Science 1993; 260: 547-549.
9. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, . A functional Interleukin- 12 receptor complex is composed of two b-type cytokine receptor subunits. Proc Natl Acad Sci USA 1996; 93: 14002-14007.
10. Parham C, Parham C, Chirica M, Timans J, Vaisberg E, Travis M. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12RB1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168: 5699-5708.
11. Klinke DJ. The ratio of P40 monomer to dimer is an important determinant of IL-12 bioactivity. J Theor Biol 2006; 240: 323-335.
12. Sinigaglia F, DAmbrosio D, Panina-Bordignon P, Rogge L. Regulation of the IL-12/IL- 12R axis: a critical step in T-helper cell differentiation and effector function. Immunol Rev 1999; 170: 65-72.
13. Athie-Morales V, Smits HH, Cantrell DA, Hilkens CM. Sustained IL-12 signaling is required for Th1 development. J Immunol 2004; 172: 61-69.
14. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007; 178: 2623-2629.
15. Espert L, Dusanter-Fourt I, Chelbi-Alix MK. Negative regulation of the JAK/STAT: pathway implication in tumorigenesis. Bull Cancer 2005; 92: 845-857
16. Valentino L, Pierre J. JAK/STAT signal transduction: regulators and implications in hematological malignancies. Biochem Pharmacol 2006; 71: 713-721.
17. Ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, Zhu W, Tremblay M, David M. Identification of a nuclear Stat4 proptein tyrosine phosphatase. Mol Cell Biol 2002; 22: 5662-5668.
18. Klinke DJ, Ustyugova IV, Brundage KM, Barnett JB. Modulating temporal control of NFkappaB activation: implications for therapeutic and assay selection. Biophys J 2008; 94: 4249-4259.
19. + T cells. Nat Immunol 2002; 3: 549-557.
20. Schulz EG, Mariani L, Radbruch A, Hofer T. Sequential polarization and imprinting of type 1T helper lymphocytes by Interferon-gamma and Interleukin-12. Immunity 2009; 30: 673-683.
21. Yamada S, Tsukada J, Yoshimura A, Kubo M. Computer simulation of the role of SOCS family protein in helper T cell differentiation. Int Immunol 2006; 18: 335-345.
22. Klinke DJ. An empirical Bayesian approach for model-based inference of cellular signaling networks. BMC Bioinform 2009; 10: 371.
23. Becskei A, Grusby MJ. Contribution of IL-12R mediated feedback loop to Th1 cell differentiation. FEBS Lett 2007; 581: 5199-5206.
24. Guler ML, Jacobson NG, Gubler U, Murphy KM. T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2T helper cell type 1 phenotype development. J Immunol 1997; 159: 1767-1774.
25. Singh A, Jayaraman A, Hahn J. Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes. Biotechnol Bioeng 2006; 95: 852-862.
26. Lei JT, Martinez-Moczygemba M. Separate endocytic pathways regulate IL-5 receptor internalization and signaling. J Leukocyte Biol 2008; 84: 1-11.
27. Guler ML, Gorham JD, Dietrich WF, Murphy TL, Steen RG, Parvin CA. Tpm1, a locus controlling IL-12 responsiveness, acts by a cell-autonomous mechanism. J Immunol 1999; 162: 1339-1347.
28. Hoffman A, Levchenko A, Scott ML, Baltimore D. The IkB-NF-kB signaling module: temporal control and selective gene activation. Science 2002; 298:1241-1245.
29. Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 2004; 38: 147-150.
30. Nelson DE, See V, Nelson G, White MR. Oscillations in transcription factor dynamics: a new way to control gene expression. Biochem Soc Trans 2004; 32: 1090-1092. (Pubitemid 39655554)
31. Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th 2 cells: implications for Th cell lineage commitment and maintenance. J Immunol 2002; 168: 3181-3187.
32. + T cells controls the direction of the Th cell response. Intl Immunol 2002; 14: 1-11.
33. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995; 2: 665-675.
34. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exptl Med 1997; 185: 817-824.
35. Yaffe MB. Signaling networks and mathematics. Sci Signal 2008; 1: eg7.
36. Broadbelt LJ, Pfaendtner J. Lexicography of kinetic modeling of complex reaction networks. AIChE J 2005; 51: 2112-2121.
37. National Research Council (US) Committee on Learning, Research, Practice and Education. How People Learn: Brain, Mind, Experience, and School. National Academies Press: Washington, DC, 2000.
38. Banga JR. Optimization in computational systems biology. Bmc Syst Bio 2008; 2.
39. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. Texts in Statistical Science. Chapman and Hall: Boca Raton, FL, 2004.
40. Presky DH, Minetti LJ, Gillessen S, Wilkinson VL, Wu CY, Gubler U, . Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. J Immunol 1998; 160: 2174-2179.
41. Park WR, Park CS, Tomura M, Ahn HJ, Nakahira Y, Iwasaki M. CD28 costimulation is required not only to induce IL-12 receptor but also to render Janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells. Eur J Immunol 2001; 31: 1456-1464.
42. Klinke DJ, Brundage KM. Scalable analysis of flow cytometry data using R/Bioconductor. Cytometry A 2009; 75: 699-706.
43. Faeder JR, Blinov ML, Goldstein B, Hlavacek WS. Rule-based modeling of biochemical networks. Complexity 2005; 10: 22-41.
44. Pawson T, Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 2003; 300: 445-452.
45. Yamamoto K, Shibata F, Miura O, Kamiyama R, Hirosawa S, Miyasaka N. Physical interaction between interleukin-12 receptor beta 2 subunit and Jak2 tyrosine kinase: Jak2 associates with cytoplasmic membrane-proximal region of interleukin-12 receptor beta 2 via amino-terminus. Biochem Biophys Res Commun 1999; 257: 400-404.
46. Lund RJ, Chen Z, Scheinin J, Lahesmaa R. Early target genes of IL-12 and STAT4 in signaling in Th cells. J Immunol 2004; 172: 6775-6782.
47. Devergne O, Ghiglione C, Noselli S. The endocytic control of JAK/STAT signalling in Drosophila. J Cell Sci 2007; 120: 3457-3464.
48. Lauffenburger DA, Linderman JJ. Receptors: Models for Binding, Trafficking and Signaling. Oxford University Press: New York, 1993.
49. OShea JJ, Murray PJ. Cytokine signaling modules in inflammatory responses. Immunity 2008; 28: 477-487.
50. Nakahira M, Tanaka T, Robson BE, Mizgerd JP, Grusby MJ. Regulation of signal transducer and activator of transcription signaling by the tyrosine phosphatase PTPBL. Immunity 2007; 26: 163-176.
51. Kholodenko BN, Demin OV, Moehren G, Hoek JB. Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 1999; 274: 30169-30181.
52. Yamada S, Shiono S, Joo A, Yoshimura A. Control mechanism of JAK/STAT signal transduction pathway. FEBS Lett 2003; 534: 190-196.
53. Koster M, Hauser H. Dynamic redistribution of STAT1 protein in IFN signaling visualized by GFP fusion proteins. Eur J Biochem 1999; 260: 137-144.
54. Chizzonite R, Truitt T, Desai BB, Nunes P, Podlaski FJ, Stern AS. IL-12 receptor I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts. J Immunol 1992; 148: 3117-3124.
55. Beers KJ. Numerical Methods for Chemical Engineering. Applications in Matlab. Cambridge University Press: Cambridge, 2007.
56. Khoo MCK. Physiological Control Systems: Analysis, Simulation, and Estimation. IEEE Press: Piscataway, NJ, USA, 2000.
57. Gelman A, Rubin D. Inference form iterative simulation using multiple sequences. Stat Sci 1992; 7: 457-474.
58. Brooks S, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 1998; 7: 434-455.